1-13 of 13
Edouard Randriamalala
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

Clinical Trials & Observations
Murielle Roussel, Valérie Lauwers-Cances, Margaret Macro, Xavier Leleu, Bruno Royer, Cyrille Hulin, Lionel Karlin, Aurore Perrot, Cyrille Touzeau, Marie-Lorraine Chrétien, Sophie Rigaudeau, Mamoun Dib, Emmanuelle Nicolas-Virelizier, Martine Escoffre-Barbe, Karim Belhadj, Clara Mariette, Anne-Marie Stoppa, Carla Araujo, Chantal Doyen, Jean Fontan, Brigitte Kolb, Laurent Garderet, Sabine Brechignac, Jean-Valère Malfuson, Arnaud Jaccard, Pascal Lenain, Cécile Borel, Benjamin Hebraud, Omar Benbrahim, Véronique Dorvaux, Salomon Manier, Karine Augeul-Meunier, Marie-Christiane Vekemans, Edouard Randriamalala, Driss Chaoui, Jo Caers, Carine Chaleteix, Lofti Benboubker, Laure Vincent, Sylvie Glaisner, Patricia Zunic, Borhane Slama, Jean-Richard Eveillard, Catherine Humbrecht-Kraut, Véronique Morel, Philippe Mineur, Jean-Claude Eisenmann, Hélène Demarquette, Valentine Richez, Marguerite Vignon, Denis Caillot, Thierry Facon, Philippe Moreau, Anne-Laurène Colin, Pascale Olivier, Soraya Wuilleme, Hervé Avet-Loiseau, Jill Corre, Michel Attal
Journal: Blood
Blood (2022) 139 (18): 2747–2757.
https://doi.org/10.1182/blood.2021014635
Published: 2022
Includes: Supplemental data
Journal Articles

Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup

Clinical Trials & Observations
Marie-Anne Hospital, Thomas Prebet, Sarah Bertoli, Xavier Thomas, Emmanuelle Tavernier, Thorsten Braun, Cécile Pautas, Aurore Perrot, Bruno Lioure, Philippe Rousselot, Jérôme Tamburini, Thomas Cluzeau, Johanna Konopacki, Edouard Randriamalala, Céline Berthon, Marie-Pierre Gourin, Christian Recher, Jean-Yves Cahn, Norbert Ifrah, Hervé Dombret, Nicolas Boissel
Journal: Blood
Blood (2014) 124 (8): 1312–1319.
https://doi.org/10.1182/blood-2014-01-549212
Published: 2014
Journal Articles

SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALL

Clinical Trials & Observations Brief Report
Raouf Ben Abdelali, Anne Roggy, Thibaut Leguay, Agata Cieslak, Aline Renneville, Aurore Touzart, Anne Banos, Edouard Randriamalala, Denis Caillot, Bruno Lioure, Alain Devidas, Hossein Mossafa, Claude Preudhomme, Norbert Ifrah, Hervé Dombret, Elizabeth Macintyre, Vahid Asnafi
Journal: Blood
Blood (2014) 123 (12): 1860–1863.
https://doi.org/10.1182/blood-2013-08-521518
Published: 2014
Includes: Supplemental data
Journal Articles

Maintenance Therapy With Alternating Azacytidine and Lenalidomide Cycles In Elderly (≥ 60) Fit Patients (Pts) With Poor Prognosis AML In First Complete Remission (CR) After Lia Induction. A Phase II Multicentric Goelams Trial

Mathilde Hunault-Berger, MD, PhD, Edouard Randriamalala, MD, Aline Schmidt-Tanguy, MD, Chantal Himberlin, MD, Bachra Choufi, MD, Caroline Bonmati, MD, Jean Yves Cahn, MD, MD marie-Anne Couturier, Eric Deconinck, MD, PhD, Jean Pierre Marolleau, MD, PhD, Frederique orisni-Piocelle, MD, Jacques Delaunay, MD, Emmanuelle Tavernier, MD, Christian Recher, MD PhD, Severine Lissandre, MD, Mario Ojeda-Uribe, MD, Laurence Sanhes, MD, Laurent Sutton, MD, Anne Banos, MD, Bruno Lioure, MD, Thierry Lamy, MD, PhD, Didier Bouscary, MD, Alain Saad, MD, Valérie Rouille, Philippe Guardiola, MD, Isabelle Luquet, MD, MD marie-Christine Bene, Francois Dreyfus, MD, Norbert Ifrah, MD, Arnaud Pigneux, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2691.
https://doi.org/10.1182/blood.V122.21.2691.2691
Published: 2013
Journal Articles

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study

Clinical Trials & Observations
Bruno Lioure, Marie C. Béné, Arnaud Pigneux, Anne Huynh, Patrice Chevallier, Nathalie Fegueux, Didier Blaise, Brigitte Witz, Martine Delain, Jérôme Cornillon, Isabelle Luquet, Odile Blanchet, Pascale Cornillet-Lefebvre, Martin Carré, Mathilde Hunault, Fabrice Larosa, Thierry Lamy, Edouard Randriamalala, Mario Ojeda-Uribe, Christian Berthou, Luc Fornecker, Jean-Luc Harousseau, Didier Bouscary, Norbert Ifrah, Jean-Yves Cahn
Journal: Blood
Blood (2012) 119 (12): 2943–2948.
https://doi.org/10.1182/blood-2011-05-352989
Published: 2012
Journal Articles

Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma

CME
Philippe Moreau, Herve Avet-Loiseau, Thierry Facon, Michel Attal, Mourad Tiab, Cyrille Hulin, Chantal Doyen, Laurent Garderet, Edouard Randriamalala, Carla Araujo, Gérard Lepeu, Gerald Marit, Denis Caillot, Martine Escoffre, Bruno Lioure, Lotfi Benboubker, Brigitte Pégourié, Brigitte Kolb, Anne Marie Stoppa, Jean-Gabriel Fuzibet, Olivier Decaux, Mamoun Dib, Christian Berthou, Carine Chaleteix, Catherine Sebban, Catherine Traullé, Jean Fontan, Marc Wetterwald, Pascal Lenain, Claire Mathiot, Jean-Luc Harousseau
Journal: Blood
Blood (2011) 118 (22): 5752–5758.
https://doi.org/10.1182/blood-2011-05-355081
Published: 2011
Journal Articles

Gemtuzumab Ozogamicin-Based Salvage, Followed by Allogeneic Hematopoietic Stem Cell Transplantation, Is Highly Effective in Young Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) in First Relapse

Marie-Anne Hospital, Christian Recher, MD, PhD, Xavier Thomas, Emmanuelle Tavernier, Bruno Lioure, Cécile Pautas, Aurore Perrot, Thorsten Braun, MD, Thomas Cluzeau, Jean-Valère Malfuson, Jerome Tamburini, Céline Berthon, MD, Alexis Magda, Chantal Himberlin, Stephane de Botton, Edouard Randriamalala, Isabelle Plantier, Madalina Uzunov, Philippe Rousselot, Norbert Ifrah, Herve Dombret, Nicolas Boissel
Journal: Blood
Blood (2011) 118 (21): 2603.
https://doi.org/10.1182/blood.V118.21.2603.2603
Published: 2011
Journal Articles

Single-Agent Dasatinib Does Not Prevent Hematological Relapse in Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) in First Complete Remission, but Persistent or Re-Appearing Molecular Minimal Residual Disease–Results of the DASA-CBF Trial From the French AML Intergroup

Nicolas Boissel, Eric Jourdan, Arnaud Pigneux, MD, PhD, Odile Blanchet, Aline Renneville, Christian Recher, MD, PhD, Emmanuel Raffoux, MD, PhD, Pascale Cornillet-Lefebvre, Jean-Michel Cayuela, Jacques Delaunay, Eric Delabesse, Claude-Eric Bulabois, Céline Berthon, Cécile Pautas, Norbert Vey, MD, Bruno Lioure, Xavier Thomas, Leila Kammoun, MD, Edouard Randriamalala, Nathalie Fegueux, Thibaud Lecerf, Marie-Christine Béné, Claude Preudhomme, Hesham Mohamed, Hervé Dombret, Norbert Ifrah
Journal: Blood
Blood (2011) 118 (21): 2608.
https://doi.org/10.1182/blood.V118.21.2608.2608
Published: 2011
Journal Articles

Gene Mutations and Minimal Residual Disease (MRD) As Predictors of Remission Duration in Adults with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Treated with High-Dose Cytarabine (HDAC) - First Results of the Prospective French Intergroup CBF-2006 Trial

Eric Jourdan, Nicolas Boissel, Odile Blanchet, Aline Renneville, Christian Recher, MD, PhD, Emmanuel Raffoux, MD, PhD, Pascale Cornillet-Lefebvre, Jean-Michel Cayuela, Jacques Delaunay, Arnaud Pigneux, MD, PhD, Eric Delabesse, Claude-Eric Bulabois, Céline Berthon, Cécile Pautas, Norbert Vey, MD, Bruno Lioure, Xavier Thomas, Nathalie Contentin, Edouard Randriamalala, Nathalie Fegueux, Marie-Christine Béné, Julie Lejeune, Philippe Guardiola, Claude Preudhomme, Norbert Ifrah, Hervé Dombret
Journal: Blood
Blood (2011) 118 (21): 410.
https://doi.org/10.1182/blood.V118.21.410.410
Published: 2011
Journal Articles

Addition of Gemtuzumab Ozogamycin to Chemotherapy Improves Event-Free Survival but Not Overall Survival of AML Patients with Intermediate Cytogenetics Not Eligible for Allogeneic Transplantation. Results of the GOELAMS AML 2006 IR Study

Jacques Delaunay, Christian Recher, MD, PhD, Arnaud Pigneux, MD, PhD, Francis Witz, MD, Norbert Vey, MD, Odile Blanchet, Pascale Lefebvre, Isabelle Luquet, Isabelle Guillerme, Christelle Volteau, Emmanuel Gyan, MD, PhD, Bruno Lioure, Eric Jourdan, Didier Bouscary, MD, PhD, Romain Guieze, MD, Edouard Randriamalala, Mario E Ojeda Uribe, MD, Francois Dreyfus, Catherine Lacombe, Marie-christine Béné, Jean-Yves Cahn, MD, Jean-Luc Harousseau, MD, Norbert Ifrah
Journal: Blood
Blood (2011) 118 (21): 79.
https://doi.org/10.1182/blood.V118.21.79.79
Published: 2011
Journal Articles

Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities

Clinical Trials & Observations
Aurore Perrot, Isabelle Luquet, Arnaud Pigneux, Francine Mugneret, Jacques Delaunay, Jean-Luc Harousseau, Carole Barin, Jean-Yves Cahn, Philippe Guardiola, Chantal Himberlin, Christian Recher, Norbert Vey, Bruno Lioure, Mario Ojeda-Uribe, Nathalie Fegueux, Christian Berthou, Edouard Randriamalala, Marie C. Béné, Norbert Ifrah, Francis Witz, for the GOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang)
Journal: Blood
Blood (2011) 118 (3): 679–685.
https://doi.org/10.1182/blood-2010-09-307264
Published: 2011
Journal Articles

Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myélome (IFM)

Clinical Trials & Observations
Murielle Roussel, Philippe Moreau, Anne Huynh, Jean-Yves Mary, Clotaire Danho, Denis Caillot, Cyrille Hulin, Christophe Fruchart, Gérald Marit, Brigitte Pégourié, Pascal Lenain, Carla Araujo, Brigitte Kolb, Edouard Randriamalala, Bruno Royer, Anne-Marie Stoppa, Mammoun Dib, Véronique Dorvaux, Laurent Garderet, Claire Mathiot, Hervé Avet-Loiseau, Jean-Luc Harousseau, Michel Attal, for the Intergroupe Francophone du Myélome (IFM)
Journal: Blood
Blood (2010) 115 (1): 32–37.
https://doi.org/10.1182/blood-2009-06-229658
Published: 2010
Journal Articles

Absolute Lymphocyte Count at 1st Remission Is Prognostic Factor for Disease Free and Overall Survival for Acute Myeloid Leukemia Under 60: Analysis of AML1 GOELAMS Trial

Bruno Lioure, MD, Christian Recher, M.D., Ph.D, Patrice Chevallier, MD, Arnaud Pigneux, MD, PhD, Francis Witz, Norbert Vey, MD, Nathalie Fegueux, MD, Claude-Eric Bulabois, Sylvie Daliphard, Fabrice Larosa, Martine Escoffre-Barbe, MD, Eric Jourdan, MD, PhD, Olivier Tournilhac, MD, PhD, Martine Delain, MD, Denis Caillot, Mario Ojeda, MD, Edouard Randriamalala, MD, Roselyne Delepine, Francois Dreyfus, Norbert Ifrah, MD
Journal: Blood
Blood (2008) 112 (11): 2520.
https://doi.org/10.1182/blood.V112.11.2520.2520
Published: 2008